BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30807002)

  • 1. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
    Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
    Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
    Inaba K; Murata K; Naruto S; Matsuda H
    J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harpagoside: from Kalahari Desert to pharmacy shelf.
    Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
    Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
    Joubert E; Manley M; Gray BR; Schulz H
    J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N; Heard C
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
    J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
    Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
    J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
    Modarai M; Suter A; Kortenkamp A; Heinrich M
    J Pharm Pharmacol; 2011 Mar; 63(3):429-38. PubMed ID: 21749392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
    Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
    Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
    Anauate MC; Torres LM; de Mello SB
    Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM; Cole D
    J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
    Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
    BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Barcode Authentication of Devil's Claw Herbal Dietary Supplements.
    Diaz-Silveira GL; Deutsch J; Little DP
    Plants (Basel); 2021 Sep; 10(10):. PubMed ID: 34685813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
    Menghini L; Recinella L; Leone S; Chiavaroli A; Cicala C; Brunetti L; Vladimir-Knežević S; Orlando G; Ferrante C
    Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity.
    Betancor-Fernández A; Pérez-Gálvez A; Sies H; Stahl W
    J Pharm Pharmacol; 2003 Jul; 55(7):981-6. PubMed ID: 12906755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
    Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
    Hostanska K; Melzer J; Rostock M; Suter A; Saller R
    J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.